AMY VOLKMANN: Open Payments
NPI 1295048643 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,974 in 131 payments from 16 companies in 2025. Trend: 2023 $2,572 · 2024 $3,286 · 2025 $2,974
Food & beverage: $2,905Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $614 |
| Novartis Pharmaceuticals Corporation | 16 | $480 |
| UCB, Inc. | 16 | $356 |
| Janssen Biotech, Inc. | 19 | $325 |
| GENZYME CORPORATION | 13 | $301 |
| LEO Pharma Inc. | 6 | $169 |
| Regeneron Healthcare Solutions, Inc. | 7 | $167 |
| Amgen Inc. | 7 | $163 |
| Incyte Corporation | 4 | $90 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $73 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, TREMFYA, RINVOQ, ADBRY, OTEZLA, COSENTYX.
Industry payments across VA — which companies pay providers there.
